Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pemphigus, Benign Familial | 2 | 2018 | 11 | 1.170 |
Why?
|
| Epigenomics | 2 | 2021 | 196 | 0.820 |
Why?
|
| Retroviridae | 2 | 2018 | 198 | 0.720 |
Why?
|
| Histone Demethylases | 1 | 2021 | 43 | 0.720 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 54 | 0.710 |
Why?
|
| Dioxygenases | 1 | 2021 | 65 | 0.710 |
Why?
|
| Tumor Virus Infections | 2 | 2018 | 140 | 0.700 |
Why?
|
| Lymphangioma | 1 | 2019 | 24 | 0.610 |
Why?
|
| Blister | 1 | 2019 | 22 | 0.610 |
Why?
|
| Merkel cell polyomavirus | 1 | 2018 | 3 | 0.610 |
Why?
|
| DNA Methylation | 3 | 2021 | 1140 | 0.590 |
Why?
|
| Calcineurin Inhibitors | 1 | 2018 | 29 | 0.580 |
Why?
|
| Papillomaviridae | 1 | 2018 | 189 | 0.550 |
Why?
|
| Skin Neoplasms | 3 | 2018 | 893 | 0.520 |
Why?
|
| Quantitative Trait Loci | 5 | 2024 | 314 | 0.460 |
Why?
|
| Psoriasis | 3 | 2019 | 48 | 0.450 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 2145 | 0.400 |
Why?
|
| Body Height | 2 | 2024 | 228 | 0.310 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 2651 | 0.310 |
Why?
|
| Genome-Wide Association Study | 4 | 2024 | 1838 | 0.300 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 168 | 0.290 |
Why?
|
| Autoantibodies | 2 | 2019 | 464 | 0.250 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1965 | 0.220 |
Why?
|
| CpG Islands | 2 | 2021 | 347 | 0.210 |
Why?
|
| Genetic Linkage | 1 | 2024 | 480 | 0.200 |
Why?
|
| Cognition | 2 | 2019 | 818 | 0.190 |
Why?
|
| Phenotype | 5 | 2024 | 4577 | 0.180 |
Why?
|
| Chromosome Mapping | 2 | 2021 | 1118 | 0.180 |
Why?
|
| Genomic Imprinting | 1 | 2021 | 130 | 0.170 |
Why?
|
| Education, Medical, Continuing | 2 | 2018 | 143 | 0.170 |
Why?
|
| Primary Prevention | 2 | 2018 | 180 | 0.170 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2020 | 13 | 0.170 |
Why?
|
| Herpesvirus 3, Human | 1 | 2020 | 30 | 0.170 |
Why?
|
| Herpes Zoster | 1 | 2020 | 26 | 0.170 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2020 | 30 | 0.160 |
Why?
|
| Gliadin | 1 | 2019 | 5 | 0.160 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 4 | 0.160 |
Why?
|
| ADAMTS Proteins | 1 | 2019 | 9 | 0.160 |
Why?
|
| Consanguinity | 1 | 2019 | 120 | 0.160 |
Why?
|
| Body Size | 1 | 2019 | 69 | 0.150 |
Why?
|
| Cardiovascular System | 1 | 2020 | 110 | 0.150 |
Why?
|
| Lasers, Gas | 1 | 2019 | 7 | 0.150 |
Why?
|
| Arthritis, Psoriatic | 1 | 2019 | 13 | 0.150 |
Why?
|
| Autoantigens | 1 | 2019 | 115 | 0.150 |
Why?
|
| Mastocytosis, Cutaneous | 1 | 2019 | 5 | 0.150 |
Why?
|
| Skin Diseases, Infectious | 1 | 2019 | 25 | 0.150 |
Why?
|
| Risk-Taking | 1 | 2019 | 102 | 0.150 |
Why?
|
| Deltaretrovirus | 1 | 2018 | 5 | 0.150 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2019 | 39 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 232 | 0.150 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2019 | 40 | 0.150 |
Why?
|
| Anti-Allergic Agents | 1 | 2019 | 27 | 0.150 |
Why?
|
| Low-Level Light Therapy | 1 | 2019 | 19 | 0.150 |
Why?
|
| Omalizumab | 1 | 2019 | 35 | 0.150 |
Why?
|
| Humans | 20 | 2024 | 133279 | 0.150 |
Why?
|
| Thorax | 1 | 2019 | 73 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2018 | 7 | 0.150 |
Why?
|
| Life Style | 1 | 2021 | 459 | 0.150 |
Why?
|
| Transcriptome | 2 | 2022 | 1135 | 0.150 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 767 | 0.150 |
Why?
|
| Triamcinolone | 1 | 2018 | 15 | 0.150 |
Why?
|
| Herpesviridae | 1 | 2018 | 35 | 0.140 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 245 | 0.140 |
Why?
|
| Clindamycin | 1 | 2018 | 42 | 0.140 |
Why?
|
| Axilla | 1 | 2018 | 44 | 0.140 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 68 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2024 | 1713 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 233 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2018 | 1584 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2855 | 0.140 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2018 | 15 | 0.140 |
Why?
|
| Skin Ulcer | 1 | 2018 | 32 | 0.140 |
Why?
|
| Homozygote | 2 | 2019 | 562 | 0.140 |
Why?
|
| Fertility | 1 | 2019 | 270 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 414 | 0.130 |
Why?
|
| Exanthema | 1 | 2018 | 71 | 0.130 |
Why?
|
| Neck | 1 | 2018 | 143 | 0.130 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2020 | 285 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 674 | 0.130 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 789 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1915 | 0.130 |
Why?
|
| Biomarkers | 3 | 2020 | 3416 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2020 | 828 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 343 | 0.120 |
Why?
|
| DNA | 1 | 2021 | 1676 | 0.120 |
Why?
|
| Proteomics | 1 | 2019 | 605 | 0.120 |
Why?
|
| Male | 10 | 2024 | 65532 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 314 | 0.120 |
Why?
|
| Prognosis | 3 | 2020 | 5042 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1730 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1163 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2020 | 3417 | 0.100 |
Why?
|
| Genomics | 1 | 2020 | 1677 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2018 | 3719 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3363 | 0.080 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2020 | 97 | 0.080 |
Why?
|
| Middle Aged | 6 | 2020 | 28956 | 0.080 |
Why?
|
| Female | 10 | 2024 | 71459 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2577 | 0.060 |
Why?
|
| Young Adult | 1 | 2019 | 9921 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 1307 | 0.060 |
Why?
|
| Siblings | 1 | 2024 | 202 | 0.050 |
Why?
|
| Adult | 5 | 2020 | 31651 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 587 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2021 | 111 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2020 | 22 | 0.040 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2020 | 21 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 424 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 31 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 24 | 0.040 |
Why?
|
| Swine | 1 | 2024 | 1205 | 0.040 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2020 | 65 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2020 | 35 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 317 | 0.040 |
Why?
|
| Cathelicidins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 400 | 0.040 |
Why?
|
| Hepatitis Viruses | 1 | 2018 | 3 | 0.040 |
Why?
|
| Pruritus | 1 | 2019 | 42 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2019 | 131 | 0.040 |
Why?
|
| Proteome | 1 | 2020 | 282 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5199 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 171 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 545 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 265 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 592 | 0.030 |
Why?
|
| Fingers | 1 | 2018 | 68 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2018 | 72 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 362 | 0.030 |
Why?
|
| Genotype | 1 | 2024 | 2720 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2020 | 417 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 313 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 606 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2018 | 674 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 401 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1608 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2020 | 872 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 85 | 0.030 |
Why?
|
| Smoking | 1 | 2020 | 944 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2207 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1697 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 173 | 0.030 |
Why?
|
| Proteins | 1 | 2020 | 1090 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1202 | 0.030 |
Why?
|
| Educational Status | 1 | 2015 | 294 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2015 | 254 | 0.030 |
Why?
|
| Asthma | 1 | 2020 | 807 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 609 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 36215 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 3106 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2015 | 1411 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 7137 | 0.020 |
Why?
|
| Genome, Human | 1 | 2015 | 1340 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10954 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13099 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21479 | 0.010 |
Why?
|